No items found.

Intended isocaloric time-restricted eating shifts circadian clocks but does not improve cardiometabolic health in women with overweight

Autoren

Beeke Peters, Julia Schwarz, Bettina Schuppelius, Agnieszka Ottawa, Daniela A Koppold, Daniela Weber, Nico Steckhan, Knut Mai, Tilman Grune, Andreas F H Pfeiffer, Andreas Michalsen, Achim Kramer, Olga Pivovarova-Ramich

Journal

Science Translational Medicine

Abstract

Time-restricted eating (TRE) is a promising strategy to improve metabolic outcomes. However, it remains unclear whether TRE has cardiometabolic benefits in an isocaloric setting and whether its effects depend on the eating timing. We conducted a randomized crossover trial in 31 women with overweight or obesity to directly compare the effects of a 2-week early TRE (eTRE; eating from 8:00 to 16:00) and a 2-week late TRE (lTRE; eating from 13:00 to 21:00) on insulin sensitivity, cardiometabolic risk factors, and the internal circadian phase. During the restricted 8-hour eating period, participants were asked to consume their habitual food quality and quantity. Insulin sensitivity did not differ between (-0.07; 95% CI, -0.77 to 0.62; P = 0.60) or within (eTRE: 0.31; 95% CI, -0.14 to 0.76; P = 0.11; lTRE: 0.19; 95% CI, -0.22 to 0.60; P = 0.25) interventions. Twenty-four-hour glucose, lipid, inflammatory, and oxidative stress markers showed no clinically meaningful between- or within-intervention differences. Participants demonstrated high timely adherence (eTRE, 96.5%; lTRE, 97.7%), unchanged dietary composition and physical activity, minor daily calorie deficit (eTRE, -167 kilocalories/day), and weight loss (eTRE, -1.08 kilograms; lTRE, -0.44 kilograms). In lTRE, the circadian phase in blood monocytes (24 minutes; 95% CI, -5 to 54 minutes; P = 0.10) and sleep midpoint (15 minutes; 95% CI, 7 to 23 minutes; P< 0.001) occurred later compared with eTRE. Overall, in an intended isocaloric setting, neither eTRE nor lTRE improves insulin sensitivity or other cardiometabolic traits, despite a shift of internal circadian clocks.

Zur Publikation

Unterstützendes Material

Autoren aus dem TRR 418

Projekte aus dem TRR 418

B01

Targeting

Circadiane Rhythmen und Chronotherapie bei Multipler Sklerose

Bei Multipler Sklerose kommt es zu Störungen von Schlaf sowie der circadianen Rhythmen von Stoffwechsel und Immunaktivität, die aktiv zur Krankheitsaktivität beitragen können. Dieses Projekt untersucht, wie diese Rhythmen den Krankheitsverlauf beeinflussen und ob deren Stärkung therapeutisch vorteilhaft sein kann.

Circadiane Rhythmen und Chronotherapie bei Multipler Sklerose

Bei Multipler Sklerose kommt es zu Störungen von Schlaf sowie der circadianen Rhythmen von Stoffwechsel und Immunaktivität, die aktiv zur Krankheitsaktivität beitragen können. Dieses Projekt untersucht, wie diese Rhythmen den Krankheitsverlauf beeinflussen und ob deren Stärkung therapeutisch vorteilhaft sein kann.